Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.
from NYT > Top Stories https://ift.tt/zenqtCI
الأربعاء، 3 مايو 2023
Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug. https://ift.tt/Lkwbd9u May 03, 2023 at 11:46PM Gina Kolata
الاشتراك في:
تعليقات الرسالة (Atom)
ليست هناك تعليقات:
إرسال تعليق